speb/financial-data huggingface dataset:
CRVS cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: -252000.00
CRVS cash_flow (annual, 2024-12-31) — Change In Payable: 1057000.00
CRVS cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 812000.00
CRVS cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: -1587000.00
CRVS cash_flow (annual, 2024-12-31) — Change In Receivables: -49000.00
CRVS cash_flow (annual, 2024-12-31) — Change In Working Capital: -1647000.00
CRVS cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -49000.00
CRVS cash_flow (annual, 2024-12-31) — Changes In Cash: -3880000.00
CRVS balance_sheet (annual, 2024-12-31) — Common Stock: 7000.00
CRVS balance_sheet (annual, 2024-12-31) — Common Stock Equity: 32568000.00
CRVS cash_flow (annual, 2024-12-31) — Common Stock Issuance: 16405000.00
CRVS balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 2616000.00
CRVS balance_sheet (annual, 2024-12-31) — Current Assets: 54407000.00
CRVS balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 185000.00
CRVS balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 185000.00
CRVS balance_sheet (annual, 2024-12-31) — Current Liabilities: 35402000.00
CRVS cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 85000.00
CRVS cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 85000.00
CRVS income_statement (annual, 2024-12-31) — Diluted Average Shares: 60985165.00
CRVS income_statement (annual, 2024-12-31) — Diluted EPS: -1.02
CRVS income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -62293000.00
CRVS income_statement (annual, 2024-12-31) — EBIT: -27548000.00
CRVS income_statement (annual, 2024-12-31) — EBITDA: -27463000.00
CRVS income_statement (annual, 2024-12-31) — Earnings From Equity Interest: -3197000.00
CRVS cash_flow (annual, 2024-12-31) — Earnings Losses From Equity Investments: 3197000.00
CRVS cash_flow (annual, 2024-12-31) — End Cash Position: 8740000.00
CRVS cash_flow (annual, 2024-12-31) — Financing Cash Flow: 49028000.00
CRVS cash_flow (annual, 2024-12-31) — Free Cash Flow: -25424000.00
CRVS cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 33377000.00
CRVS cash_flow (quarterly, 2024-12-31) — Gain Loss On Investment Securities: 2347000.00
CRVS cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: -5000.00
CRVS income_statement (annual, 2024-12-31) — Gain On Sale Of Ppe: 5000.00
CRVS income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -33377000.00
CRVS income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: -2347000.00
CRVS balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -1288000.00
CRVS income_statement (annual, 2024-12-31) — General And Administrative Expense: 8163000.00
CRVS balance_sheet (annual, 2024-12-31) — Gross PPE: 5954000.00
CRVS income_statement (annual, 2024-12-31) — Interest Income: 1824000.00
CRVS income_statement (annual, 2024-12-31) — Interest Income Non Operating: 1824000.00
CRVS balance_sheet (annual, 2024-12-31) — Invested Capital: 32568000.00
CRVS cash_flow (annual, 2024-12-31) — Investing Cash Flow: -27484000.00
CRVS balance_sheet (annual, 2024-12-31) — Investments And Advances: 12540000.00
CRVS balance_sheet (annual, 2024-12-31) — Investmentsin Associatesat Cost: 12540000.00
CRVS cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 16405000.00
CRVS balance_sheet (annual, 2024-12-31) — Leases: 2084000.00
CRVS balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 937000.00
CRVS balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 937000.00
CRVS balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 12540000.00
CRVS balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 171000.00
CRVS cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 16405000.00
CRVS income_statement (annual, 2024-12-31) — Net Income: -62293000.00
CRVS income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -62293000.00
CRVS income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -62293000.00
CRVS income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -62293000.00
CRVS income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -62293000.00
CRVS cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -62293000.00
CRVS income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -62293000.00
CRVS income_statement (annual, 2024-12-31) — Net Interest Income: 1824000.00
CRVS cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -27489000.00
CRVS income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 1824000.00
CRVS balance_sheet (annual, 2024-12-31) — Net PPE: 1328000.00
CRVS cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: 5000.00
CRVS balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 32568000.00
CRVS income_statement (annual, 2024-12-31) — Normalized EBITDA: 5909000.00
CRVS income_statement (annual, 2024-12-31) — Normalized Income: -28921000.00
CRVS cash_flow (annual, 2024-12-31) — Operating Cash Flow: -25424000.00
CRVS cash_flow (annual, 2024-12-31) — Operating Gains Losses: 36569000.00
CRVS income_statement (annual, 2024-12-31) — Operating Income: -27548000.00
CRVS income_statement (annual, 2024-12-31) — Operating Revenue: 0.00
CRVS balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 67899779.00
CRVS balance_sheet (annual, 2024-12-31) — Other Current Assets: 548000.00
CRVS balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 29199000.00
CRVS balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -1288000.00
CRVS income_statement (annual, 2024-12-31) — Other Gand A: 8163000.00
CRVS income_statement (annual, 2024-12-31) — Other Income Expense: -36569000.00
CRVS balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 632000.00
CRVS balance_sheet (annual, 2024-12-31) — Other Properties: 3699000.00
CRVS balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 43224000.00
CRVS balance_sheet (annual, 2024-12-31) — Payables: 2582000.00
CRVS balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 5198000.00
CRVS balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 820000.00
CRVS balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
CRVS balance_sheet (annual, 2024-12-31) — Prepaid Assets: 1679000.00
CRVS income_statement (annual, 2024-12-31) — Pretax Income: -62293000.00
CRVS cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 32623000.00
CRVS balance_sheet (annual, 2024-12-31) — Properties: 0.00
CRVS cash_flow (annual, 2024-12-31) — Purchase Of Investment: -70119000.00
CRVS cash_flow (annual, 2024-12-31) — Purchase Of PPE: 0.00
CRVS balance_sheet (annual, 2024-12-31) — Receivables: 216000.00
CRVS income_statement (annual, 2024-12-31) — Reconciled Depreciation: 85000.00
CRVS income_statement (annual, 2024-12-31) — Research And Development: 19385000.00
CRVS balance_sheet (annual, 2024-12-31) — Retained Earnings: -397010000.00
CRVS cash_flow (annual, 2024-12-31) — Sale Of Investment: 42630000.00
CRVS cash_flow (annual, 2024-12-31) — Sale Of PPE: 5000.00
CRVS income_statement (annual, 2024-12-31) — Selling General And Administration: 8163000.00
CRVS balance_sheet (annual, 2024-12-31) — Share Issued: 67899779.00
CRVS income_statement (annual, 2024-12-31) — Special Income Charges: 5000.00
CRVS cash_flow (annual, 2024-12-31) — Stock Based Compensation: 3003000.00
CRVS balance_sheet (annual, 2024-12-31) — Stockholders Equity: 32568000.00
CRVS balance_sheet (annual, 2024-12-31) — Tangible Book Value: 32568000.00
CRVS income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
CRVS income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
CRVS balance_sheet (annual, 2024-12-31) — Total Assets: 68907000.00
CRVS balance_sheet (annual, 2024-12-31) — Total Capitalization: 32568000.00
CRVS balance_sheet (annual, 2024-12-31) — Total Debt: 1122000.00
CRVS balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 32568000.00
CRVS income_statement (annual, 2024-12-31) — Total Expenses: 27548000.00
CRVS balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 36339000.00
CRVS balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 14500000.00
CRVS balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 937000.00
CRVS income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -27548000.00
CRVS income_statement (annual, 2024-12-31) — Total Unusual Items: -33372000.00
CRVS income_statement (quarterly, 2024-12-31) — Total Unusual Items: -2342000.00
CRVS income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -33372000.00
CRVS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: -2342000.00
CRVS balance_sheet (annual, 2024-12-31) — Working Capital: 19005000.00
CRVS income_statement (quarterly, 2025-03-31) — +Operating Expense: 9922000.00
CRVS income_statement (quarterly, 2025-03-31) — +Total Revenue: 0.00
CRVS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 1308000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 79000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Accrued Interest Receivable: 148000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -2564000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 432389000.00
CRVS cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: -291000.00
CRVS income_statement (quarterly, 2025-03-31) — Average Dilution Earnings: -25129000.00
CRVS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 72126496.00
CRVS income_statement (quarterly, 2025-03-31) — Basic EPS: 0.21
CRVS cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 8740000.00
CRVS cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -36000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 1153000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 7000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 4999000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 44212000.00
CRVS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 279000.00
CRVS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 4243000.00
CRVS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -8263000.00
CRVS cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -1274000.00
CRVS cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: 146000.00
CRVS cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 85000.00
CRVS cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: 31000.00
CRVS cash_flow (quarterly, 2025-03-31) — Change In Payable: -1274000.00
CRVS cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -1128000.00
CRVS cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 1168000.00
CRVS cash_flow (quarterly, 2025-03-31) — Change In Receivables: -4000.00
CRVS cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 152000.00
CRVS cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -4000.00
CRVS cash_flow (quarterly, 2025-03-31) — Changes In Cash: -3741000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Common Stock: 7000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 49325000.00
CRVS cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
CRVS balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 2849000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Current Assets: 45491000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 319000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 319000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 9279000.00
CRVS cash_flow (quarterly, 2025-03-31) — Depreciation: 22000.00
CRVS cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 22000.00
CRVS cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 22000.00
CRVS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 75152514.00
CRVS income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.13
CRVS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -9936000.00
CRVS income_statement (quarterly, 2025-03-31) — EBIT: -9922000.00
CRVS income_statement (quarterly, 2025-03-31) — EBITDA: -9900000.00
CRVS income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: -539000.00
CRVS cash_flow (quarterly, 2025-03-31) — Earnings Losses From Equity Investments: 539000.00
CRVS cash_flow (quarterly, 2025-03-31) — End Cash Position: 4999000.00
CRVS cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 279000.00
CRVS cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -8299000.00
CRVS cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -25129000.00
CRVS income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 25129000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -1254000.00
CRVS income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 2469000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 3824000.00
CRVS income_statement (quarterly, 2025-03-31) — Interest Income: 525000.00
CRVS income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 525000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 49325000.00
CRVS cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 4243000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 12058000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Investmentsin Associatesat Cost: 12058000.00
CRVS cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
CRVS balance_sheet (quarterly, 2025-03-31) — Leases: 17000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 834000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 834000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 12058000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 190000.00
CRVS cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
CRVS income_statement (quarterly, 2025-03-31) — Net Income: 15193000.00
CRVS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 15193000.00
CRVS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 15193000.00
CRVS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 15193000.00
CRVS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 15193000.00
CRVS cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 15193000.00
CRVS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 15193000.00
CRVS income_statement (quarterly, 2025-03-31) — Net Interest Income: 525000.00
CRVS cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 4279000.00
CRVS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 525000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Net PPE: 1260000.00
CRVS cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -36000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 49325000.00
CRVS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -35029000.00
CRVS income_statement (quarterly, 2025-03-31) — Normalized Income: -4658910.00
CRVS cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -8263000.00
CRVS cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -24590000.00
CRVS income_statement (quarterly, 2025-03-31) — Operating Income: -9922000.00
CRVS income_statement (quarterly, 2025-03-31) — Operating Revenue: 0.00
CRVS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 68169461.00
CRVS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 458000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 4077000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -1254000.00
CRVS income_statement (quarterly, 2025-03-31) — Other Gand A: 2469000.00
CRVS income_statement (quarterly, 2025-03-31) — Other Income Expense: 24590000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 629000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Other Properties: 3617000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 39213000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Payables: 1308000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 4157000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 726000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
CRVS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 594000.00
CRVS income_statement (quarterly, 2025-03-31) — Pretax Income: 15193000.00
CRVS cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 279000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
CRVS cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -7708000.00
CRVS cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -36000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Receivables: 227000.00
CRVS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 22000.00
CRVS income_statement (quarterly, 2025-03-31) — Research And Development: 7453000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -381817000.00
CRVS cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 11987000.00
CRVS income_statement (quarterly, 2025-03-31) — Selling General And Administration: 2469000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Share Issued: 68169461.00
CRVS cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 1251000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 49325000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 49325000.00
CRVS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 5277090.00
CRVS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
CRVS balance_sheet (quarterly, 2025-03-31) — Total Assets: 59438000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 49325000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Total Debt: 1153000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 49325000.00
CRVS income_statement (quarterly, 2025-03-31) — Total Expenses: 9922000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 10113000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 13947000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 834000.00
CRVS income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -9922000.00
CRVS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 25129000.00
CRVS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 25129000.00
CRVS balance_sheet (quarterly, 2025-03-31) — Working Capital: 36212000.00
CRVS income_statement (quarterly, 2025-06-30) — +Operating Expense: 10260000.00
CRVS income_statement (quarterly, 2025-06-30) — +Total Revenue: 0.00
CRVS balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 3137000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 86000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Accrued Interest Receivable: 173000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -2594000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 471184000.00
CRVS cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: -334000.00
CRVS income_statement (quarterly, 2025-06-30) — Average Dilution Earnings: 0.00
CRVS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 77774344.00
CRVS income_statement (quarterly, 2025-06-30) — Basic EPS: -0.10
CRVS cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 4999000.00
CRVS cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -113000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 1083000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Capital Stock: 7000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 14691000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 74407000.00
CRVS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 35770000.00
CRVS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -20301000.00
CRVS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -5777000.00
CRVS cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 1829000.00
CRVS cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 1142000.00
CRVS cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 86000.00
CRVS cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -70000.00
CRVS cash_flow (quarterly, 2025-06-30) — Change In Payable: 1829000.00
CRVS cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 2971000.00
CRVS cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -87000.00
CRVS cash_flow (quarterly, 2025-06-30) — Change In Receivables: -7000.00
CRVS cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 2893000.00
CRVS cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -7000.00
CRVS cash_flow (quarterly, 2025-06-30) — Changes In Cash: 9692000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Common Stock: 7000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 80228000.00
CRVS cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 0.00
CRVS balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 3848000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Current Assets: 75780000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 355000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 355000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 8505000.00
CRVS cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 29000.00
CRVS cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 29000.00
CRVS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 77774344.00
CRVS income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.10
CRVS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -7998000.00
CRVS income_statement (quarterly, 2025-06-30) — EBIT: -10260000.00
CRVS income_statement (quarterly, 2025-06-30) — EBITDA: -10231000.00
CRVS income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest: -389000.00
CRVS cash_flow (quarterly, 2025-06-30) — Earnings Losses From Equity Investments: 389000.00
CRVS cash_flow (quarterly, 2025-06-30) — End Cash Position: 14691000.00
CRVS cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 35770000.00
CRVS cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -5890000.00
CRVS cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: -2012000.00
CRVS income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 2012000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -1148000.00
CRVS income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 2387000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Gross PPE: 3855000.00
CRVS income_statement (quarterly, 2025-06-30) — Interest Income: 639000.00
CRVS income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 639000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Invested Capital: 80228000.00
CRVS cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -20301000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 11794000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Investmentsin Associatesat Cost: 11794000.00
CRVS cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 0.00
CRVS balance_sheet (quarterly, 2025-06-30) — Leases: 33000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 728000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 728000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Long Term Equity Investment: 11794000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 190000.00
CRVS cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
CRVS income_statement (quarterly, 2025-06-30) — Net Income: -7998000.00
CRVS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -7998000.00
CRVS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -7998000.00
CRVS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -7998000.00
CRVS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -7998000.00
CRVS cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -7998000.00
CRVS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -7998000.00
CRVS income_statement (quarterly, 2025-06-30) — Net Interest Income: 639000.00
CRVS cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -20188000.00
CRVS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 639000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Net PPE: 1261000.00
CRVS cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -113000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 80228000.00
CRVS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -12243000.00
CRVS income_statement (quarterly, 2025-06-30) — Normalized Income: -10010000.00
CRVS cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -5777000.00
CRVS cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -1623000.00
CRVS income_statement (quarterly, 2025-06-30) — Operating Income: -10260000.00
CRVS income_statement (quarterly, 2025-06-30) — Operating Revenue: 0.00
CRVS balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 74514039.00
CRVS balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 569000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 346000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -1148000.00
CRVS income_statement (quarterly, 2025-06-30) — Other Gand A: 2387000.00
CRVS income_statement (quarterly, 2025-06-30) — Other Income Expense: 1623000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 626000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Other Properties: 3632000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 59716000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Payables: 3137000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 6985000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 819000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
CRVS balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 545000.00
CRVS income_statement (quarterly, 2025-06-30) — Pretax Income: -7998000.00
CRVS cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 35770000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
CRVS cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -39475000.00
CRVS cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -113000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Receivables: 259000.00
CRVS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 29000.00
CRVS income_statement (quarterly, 2025-06-30) — Research And Development: 7873000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -389815000.00
CRVS cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 19287000.00
CRVS income_statement (quarterly, 2025-06-30) — Selling General And Administration: 2387000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Share Issued: 74514039.00
CRVS cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 1256000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 80228000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 80228000.00
CRVS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CRVS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
CRVS balance_sheet (quarterly, 2025-06-30) — Total Assets: 89461000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 80228000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Total Debt: 1083000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 80228000.00
CRVS income_statement (quarterly, 2025-06-30) — Total Expenses: 10260000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 9233000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 13681000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 728000.00
CRVS income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -10260000.00
CRVS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 2012000.00
CRVS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 2012000.00
CRVS balance_sheet (quarterly, 2025-06-30) — Working Capital: 67275000.00
CRVS income_statement (quarterly, 2025-09-30) — +Operating Expense: 10572000.00
CRVS income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
CRVS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 1974000.00
CRVS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 32000.00
CRVS balance_sheet (quarterly, 2025-09-30) — Accrued Interest Receivable: 314000.00
CRVS balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -2622000.00
CRVS balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 472793000.00
CRVS cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: -459000.00
CRVS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 82836369.00
CRVS income_statement (quarterly, 2025-09-30) — Basic EPS: -0.12
CRVS cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 14691000.00
CRVS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 1011000.00
CRVS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 7000.00
CRVS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 2867000.00
CRVS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 65689000.00
CRVS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 360000.00
CRVS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -2618000.00
CRVS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -9566000.00
CRVS cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -1163000.00
CRVS cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 708000.00
CRVS cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -141000.00
CRVS cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -72000.00
CRVS cash_flow (quarterly, 2025-09-30) — Change In Payable: -1163000.00
CRVS cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -455000.00
CRVS cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 64000.00
CRVS cash_flow (quarterly, 2025-09-30) — Change In Receivables: 54000.00
CRVS cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -550000.00
CRVS cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 54000.00
CRVS cash_flow (quarterly, 2025-09-30) — Changes In Cash: -11824000.00
CRVS balance_sheet (quarterly, 2025-09-30) — Common Stock: 7000.00
CRVS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 71768000.00
CRVS cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
CRVS balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 4440000.00
CRVS balance_sheet (quarterly, 2025-09-30) — Current Assets: 66944000.00
CRVS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 379000.00
CRVS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 379000.00
CRVS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 8074000.00
CRVS cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 28000.00
CRVS cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 28000.00
CRVS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 82836369.00
CRVS income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.12
CRVS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -10157000.00
CRVS income_statement (quarterly, 2025-09-30) — EBIT: -10572000.00
CRVS income_statement (quarterly, 2025-09-30) — EBITDA: -10544000.00
CRVS income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest: -323000.00
CRVS cash_flow (quarterly, 2025-09-30) — Earnings Losses From Equity Investments: 323000.00
CRVS cash_flow (quarterly, 2025-09-30) — End Cash Position: 2867000.00
CRVS cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 360000.00
CRVS cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -9566000.00
CRVS cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 0.00
CRVS balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -1060000.00
CRVS income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 2118000.00
CRVS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 3770000.00
CRVS income_statement (quarterly, 2025-09-30) — Interest Income: 738000.00
CRVS income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 738000.00
CRVS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 71768000.00
CRVS cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -2618000.00
CRVS balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 11530000.00
CRVS balance_sheet (quarterly, 2025-09-30) — Investmentsin Associatesat Cost: 11530000.00
CRVS cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
CRVS balance_sheet (quarterly, 2025-09-30) — Leases: 33000.00
CRVS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 632000.00
CRVS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 632000.00
CRVS balance_sheet (quarterly, 2025-09-30) — Long Term Equity Investment: 11530000.00
CRVS balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 190000.00
CRVS cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
CRVS income_statement (quarterly, 2025-09-30) — Net Income: -10157000.00
CRVS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -10157000.00
CRVS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -10157000.00
CRVS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -10157000.00
CRVS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -10157000.00
CRVS cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -10157000.00
CRVS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -10157000.00
CRVS income_statement (quarterly, 2025-09-30) — Net Interest Income: 738000.00
CRVS cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -2618000.00
CRVS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 738000.00
CRVS balance_sheet (quarterly, 2025-09-30) — Net PPE: 1148000.00
CRVS cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: 0.00
CRVS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 71768000.00
CRVS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -10544000.00
CRVS income_statement (quarterly, 2025-09-30) — Normalized Income: -10157000.00
CRVS cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -9566000.00
CRVS cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 323000.00
CRVS income_statement (quarterly, 2025-09-30) — Operating Income: -10572000.00
CRVS income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
CRVS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 74681872.00
CRVS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 509000.00
CRVS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 566000.00
CRVS balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -1060000.00
CRVS income_statement (quarterly, 2025-09-30) — Other Gand A: 2118000.00
CRVS income_statement (quarterly, 2025-09-30) — Other Income Expense: -323000.00
CRVS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 852000.00
CRVS balance_sheet (quarterly, 2025-09-30) — Other Properties: 3547000.00
CRVS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 62822000.00
CRVS balance_sheet (quarterly, 2025-09-30) — Payables: 1974000.00
CRVS balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 6414000.00
CRVS balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 715000.00
CRVS balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
CRVS balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 400000.00
CRVS income_statement (quarterly, 2025-09-30) — Pretax Income: -10157000.00
CRVS cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 360000.00
CRVS balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
CRVS cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -31149000.00
CRVS cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: 0.00
CRVS balance_sheet (quarterly, 2025-09-30) — Receivables: 346000.00
CRVS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 28000.00
CRVS income_statement (quarterly, 2025-09-30) — Research And Development: 8454000.00
CRVS balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -399972000.00
CRVS cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 28531000.00
CRVS income_statement (quarterly, 2025-09-30) — Selling General And Administration: 2118000.00
CRVS balance_sheet (quarterly, 2025-09-30) — Share Issued: 74681872.00
CRVS cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 1249000.00
CRVS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 71768000.00
CRVS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 71768000.00
CRVS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
CRVS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
CRVS balance_sheet (quarterly, 2025-09-30) — Total Assets: 80474000.00
CRVS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 71768000.00
CRVS balance_sheet (quarterly, 2025-09-30) — Total Debt: 1011000.00
CRVS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 71768000.00
CRVS income_statement (quarterly, 2025-09-30) — Total Expenses: 10572000.00
CRVS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 8706000.00
CRVS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 13530000.00
CRVS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 632000.00
CRVS income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -10572000.00
CRVS balance_sheet (quarterly, 2025-09-30) — Working Capital: 58870000.00
CRVS income_statement (annual, 2025-12-31) — +Operating Expense: 42971000.00
CRVS income_statement (quarterly, 2025-12-31) — +Operating Expense: 12217000.00
CRVS income_statement (annual, 2025-12-31) — +Total Revenue: 0.00
CRVS income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
CRVS balance_sheet (annual, 2025-12-31) — Accounts Payable: 2491000.00
CRVS balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 2491000.00
CRVS balance_sheet (annual, 2025-12-31) — Accounts Receivable: 37000.00
CRVS balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 37000.00
CRVS balance_sheet (annual, 2025-12-31) — Accrued Interest Receivable: 337000.00
CRVS balance_sheet (quarterly, 2025-12-31) — Accrued Interest Receivable: 337000.00
CRVS balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -2649000.00
CRVS balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -2649000.00
CRVS balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 474387000.00
CRVS balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 474387000.00
CRVS cash_flow (annual, 2025-12-31) — Amortization Of Securities: -1345000.00
CRVS cash_flow (quarterly, 2025-12-31) — Amortization Of Securities: -261000.00
CRVS income_statement (annual, 2025-12-31) — Basic Average Shares: 78964842.00
CRVS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 82960560.00
CRVS income_statement (annual, 2025-12-31) — Basic EPS: -0.19
CRVS income_statement (quarterly, 2025-12-31) — Basic EPS: -0.15
CRVS cash_flow (annual, 2025-12-31) — Beginning Cash Position: 8740000.00
CRVS cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 2867000.00
CRVS cash_flow (annual, 2025-12-31) — Capital Expenditure: -174000.00
CRVS cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -25000.00
CRVS balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 937000.00
CRVS balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 937000.00
CRVS balance_sheet (annual, 2025-12-31) — Capital Stock: 7000.00
CRVS balance_sheet (quarterly, 2025-12-31) — Capital Stock: 7000.00
CRVS balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 4576000.00
CRVS balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 4576000.00
CRVS balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 56750000.00
CRVS balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 56750000.00
CRVS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 36429000.00
CRVS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 20000.00
CRVS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -7796000.00
CRVS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 10880000.00
CRVS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -32797000.00
CRVS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -9191000.00
CRVS cash_flow (annual, 2025-12-31) — Change In Account Payable: -91000.00
CRVS cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 517000.00
CRVS cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 2761000.00
CRVS cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 765000.00
CRVS cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 115000.00
CRVS cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 85000.00
CRVS cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -185000.00
CRVS cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -74000.00
CRVS cash_flow (annual, 2025-12-31) — Change In Payable: -91000.00
CRVS cash_flow (quarterly, 2025-12-31) — Change In Payable: 517000.00
CRVS cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 2670000.00
CRVS cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 1282000.00
CRVS cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 941000.00
CRVS cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -204000.00
CRVS cash_flow (annual, 2025-12-31) — Change In Receivables: 38000.00
CRVS cash_flow (quarterly, 2025-12-31) — Change In Receivables: -5000.00
CRVS cash_flow (annual, 2025-12-31) — Change In Working Capital: 3579000.00
CRVS cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 1084000.00
CRVS cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 38000.00
CRVS cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -5000.00
CRVS cash_flow (annual, 2025-12-31) — Changes In Cash: -4164000.00
CRVS cash_flow (quarterly, 2025-12-31) — Changes In Cash: 1709000.00
CRVS balance_sheet (annual, 2025-12-31) — Common Stock: 7000.00
CRVS balance_sheet (quarterly, 2025-12-31) — Common Stock: 7000.00
CRVS balance_sheet (annual, 2025-12-31) — Common Stock Equity: 61205000.00
CRVS balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 61205000.00
CRVS cash_flow (annual, 2025-12-31) — Common Stock Issuance: 0.00
CRVS cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
CRVS balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 5607000.00
CRVS balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 5607000.00
CRVS balance_sheet (annual, 2025-12-31) — Current Assets: 58214000.00
CRVS balance_sheet (quarterly, 2025-12-31) — Current Assets: 58214000.00
CRVS balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 403000.00
CRVS balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 403000.00
CRVS balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 403000.00
CRVS balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 403000.00
CRVS balance_sheet (annual, 2025-12-31) — Current Liabilities: 9380000.00
CRVS balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 9380000.00
CRVS cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 105000.00
CRVS cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 26000.00
CRVS cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 105000.00
CRVS cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 26000.00
CRVS income_statement (annual, 2025-12-31) — Diluted Average Shares: 79742685.00
CRVS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 82960560.00
CRVS income_statement (annual, 2025-12-31) — Diluted EPS: -0.53
CRVS income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.15
CRVS income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -15283000.00
CRVS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -12321000.00
CRVS income_statement (annual, 2025-12-31) — EBIT: -42971000.00
CRVS income_statement (quarterly, 2025-12-31) — EBIT: -12217000.00
CRVS income_statement (annual, 2025-12-31) — EBITDA: -42866000.00
CRVS income_statement (quarterly, 2025-12-31) — EBITDA: -12191000.00
CRVS income_statement (annual, 2025-12-31) — Earnings From Equity Interest: -1958000.00
CRVS income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest: -707000.00
CRVS cash_flow (annual, 2025-12-31) — Earnings Losses From Equity Investments: 1958000.00
CRVS cash_flow (quarterly, 2025-12-31) — Earnings Losses From Equity Investments: 707000.00
CRVS cash_flow (annual, 2025-12-31) — End Cash Position: 4576000.00
CRVS cash_flow (quarterly, 2025-12-31) — End Cash Position: 4576000.00
CRVS cash_flow (annual, 2025-12-31) — Financing Cash Flow: 36429000.00
CRVS cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 20000.00
CRVS cash_flow (annual, 2025-12-31) — Free Cash Flow: -32971000.00
CRVS cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -9216000.00
CRVS cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -27141000.00
CRVS cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: 0.00